Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in Alzheimer's Disease
NCT01068353Phase 2Completed
- Sponsor
- University of Southampton
- Start
- Jan 2011
- Primary completion
- Dec 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in Alzheimer's disease (AD), sponsored by University of Southampton. Started Jan 2011; status: completed.
02
Drugs
etanercept
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01068353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01068353.